MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Clinical and demographics of cervical dystonia related to the direction of the neck movement

    K. Asanuma (Kyoto, Japan)

    Objective: The objectives of this report is to survey whether the type of torticollis (i.e. rotation, retrocolis and anterocolis) is related to the clinical characteristics…
  • 2017 International Congress

    Dystonia-like phenotype in a DYT1 rat model after peripheral trauma

    S. Knorr, K. Grundmann-Hauser, J. Volkmann, C.W. Ip (Wuerzburg, Germany)

    Objective: Establishment and characterization of a DYT1 rat model with dystonia-like movements after sciatic nerve crush injury. Background: Penetrance of DYT1 dystonia is markedly reduced…
  • 2017 International Congress

    The Volatility of Local Field Potential Oscillations in Dystonia and Parkinson’s disease

    D. Pina Fuentes, J. van Zijl, J.-W. Elting, G. Drost, M. van Egmond, M. Oterdoom, M. Tijssen, M. van Dijk, M. Beudel (Groningen, Netherlands)

    Objective: To assess the volatility of low frequency (4-12Hz) and beta-band (13-30Hz) oscillations in local field potentials (LFPs) in dystonia and compare this to LFPs…
  • 2017 International Congress

    Trisomy 8 Mosaicism and dystonia: a THAP1 overdose?

    A. Fois, M. Tchan, V. Fung (Westmead, Australia)

    Objective: We report a case of Trisomy 8 Mosaicism (T8M, Warkany Syndrome) with craniocervical and hand dystonia, an hitherto unreported disease association. Background: T8M is…
  • 2017 International Congress

    Differences between Hemifacial spasm with or without neurovascular conflict. Therapeutic implications with botulinum toxin type A.

    J.S. Bestoso, L. Ciancaglini, C. Stefani, C. Azcona, M.L. Contartese, A. Pappolla, J.I. Rojas, D. Bauso (Buenos Aires, Argentina)

    Objective: To evaluate the presence of possible clinical differences between patients with HS with and without neurovascular conflict (NVC +, NVC-) and their therapeutic response…
  • 2017 International Congress

    Self Perception of Dysphagia in Parkinson Disease

    A. Silbergleit, C. Sidiropoulos, R. Konnai, L. Schultz, A. Kitowski, P. LeWitt (West Bloomfield, MI, USA)

    Objective: To determine when individuals with Parkinson disease (PD) perceive impairment of swallowing as it relates to time since diagnosis.  Background: Dysphagia, and particularly silent…
  • 2017 International Congress

    Polyneuropathy in patients with Parkinson’s disease from southern Spain treatment with levodopa/carbidopa intestinal gel infusión

    F. Carrillo, S. Jesus, L. Vargas, M. Bernal, M.T. Caceres, A.D. Adarmes, M. Carballo, P. Mir (Seville, Spain)

    Objective: This study main objective is to prospectively report the 10-year incidence of polineuropathy in Parkinson´s disease patients from southern Spain treated with LCIG. Background: Patients with…
  • 2017 International Congress

    Ocular Motor Disorders Among Filipino “LUBAG” or X-Linked Dystonia Parkinsonism (XDP) Patients

    M. Macas, E.C. Rossi, S. Abantas-Diamla, A. Punzalan-Sotelo, E. Palisoc, C. Go (Manila, Philippines)

    Objective: To determine the prevalence of ocular motor disorders among X-Linked Dystonia Parkinsonism (XDP) patients seen in Jose R Reyes Memorial Medical Center, and at…
  • 2017 International Congress

    Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease: Preliminary Results from a Phase III Study

    S. Isaacson, R. Hauser, A. Espay, R. Pahwa, D. Truong, E. Pappert, P. Gardzinksi, B. Dzyngel, A. Agro, H. Fernandez (Boca Raton, FL, USA)

    Objective: To determine the safety of single treatments of APL-130277 in patients with Parkinson’s disease (PD).  Background: Patients with Parkinson’s disease (PD) frequently develop problematic…
  • 2017 International Congress

    Home-based step training using videogame technology in people with Parkinson’s disease: a randomized controlled trial

    J. SONG, S. Paul, M.J. Caetano, S. Smith, L. Dibble, R. Love, D. Schoene, J. Menant, C. Sherrington, S. Lord, C. Canning, N. Allen (Ultimo, NSW, Australia)

    Objective: To determine the effectiveness of 12 weeks of home-based exergame step training for improving stepping performance, physical and neuropsychological measures associated with falls in…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley